Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Overseas Pharmaceuticals, Ltd.
Overseas Pharmaceuticals, Ltd.
Industry · 12 registered clinical trials.
Status
Trial
Phase
Started
Completed
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting an
Idiopathic Pulmonary Fibrosis
Phase 1
2024-09-18
Completed
Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subje
Chronic Insomnia Characterized
Phase 1
2024-06-24
Completed
Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healt
Idiopathic Pulmonary Fibrosis
Phase 1
2024-04-08
Completed
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy S
Idiopathic Pulmonary Fibrosis
Phase 1
2023-08-25
Unknown
Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Ad
Pain, Insomnia
Phase 1
2023-04-03
Unknown
An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparati
Epilepsy
Phase 1
2023-04-01
Unknown
An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Health
Hypertension
Phase 1
2023-01-28
Unknown
Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasti
Hypertension
Phase 1
2022-10-28
Unknown
An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Table
Partial Seizure
Phase 1
2022-09-13
Unknown
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis o
Degenerative Arthritis
Phase 3
2021-12-10
Completed
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg
Chronic Pain
Phase 1
2020-12-24
Terminated
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Compa
Pain Control
Phase 1
2017-12-11